Moderna, Inc. and Novavax, Inc. were trading up over 10 percent and 8 percent, respectively, at one point on Wednesday, boosted by the S&P 500’s almost 2.6 percent intraday gain. The pharmaceutical stocks have been heavily beaten down over the past many months, with Moderna declining over 70 percent from its Aug. 10, 2021 all-time high of 497.49 and Novavax plummeting about 76 percent from its all-time high of 331.68 printed on Feb. 9 of that same year, when the COVID-19 pandemic plagued the global community. Both Moderna and Novavax have started to flash signals the bottom may be in, because they have developed various bullish indicators on their daily charts. It should be noted, however, that events affecting the general markets, negative or positive reactions to earnings prints and news headlines can quickly invalidate patterns and breakouts. As the saying goes, “the trend is your friend until it isn’t” and …